Squarepoint Ops LLC X4 Pharmaceuticals, Inc Transaction History

Squarepoint Ops LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.61 - $0.99 $39,505 - $64,115	64,763 New	64,763 $54,000
Q3 2021 Nov 15, 2021	SELL	$4.53 - $6.45 $93,490 - $133,115	-20,638 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$6.49 - $9.56 $2,855 - $4,206	-440 Reduced 2.09%	20,638 $134,000
Q1 2021 May 17, 2021	BUY	$6.63 - $10.28 $25,896 - $40,153	3,906 Added 22.75%	21,078 $181,000
Q4 2020 Feb 16, 2021	BUY	$5.41 - $7.4 $27,796 - $38,021	5,138 Added 42.7%	17,172 $110,000
Q3 2020 Nov 16, 2020	SELL	$6.09 - $9.15 $56,515 - $84,912	-9,280 Reduced 43.54%	12,034 $81,000
Q2 2020 Aug 14, 2020	BUY	$7.98 - $10.44 $170,085 - $222,518	21,314 New	21,314 $199,000
Q1 2020 May 15, 2020	SELL	$6.03 - $11.01 $82,454 - $150,550	-13,674 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$9.93 - $14.33 $135,782 - $195,948	13,674 New	13,674 $146,000

105

100M

213K

50.6K

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $23.3M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.